Literature DB >> 8970022

Histopathological comparison of photorefractive keratectomy and laser in situ keratomileusis in rabbits.

M Amm1, W Wetzel, M Winter, D Uthoff, G I Duncker.   

Abstract

BACKGROUND: After 193 nm excimer laser photorefractive keratectomy (PRK) for myopia, superficial opacities in the ablation zone and regression of refractive results can occur. Clinical studies have emphasized that corneal clarity and early refractive stability can be achieved with laser in situ keratomileusis (LASIK). We present clinical and histological results that compare PRK and LASIK for the treatment of myopia in rabbits.
MATERIALS AND METHODS: We treated 12 New Zealand white rabbits with PRK and 12 with LASIK using a 193-nm excimer laser (Aesculap Meditec). In both techniques, the identical excimer software and ablation parameters of -10 D treatment depth were used. Six months after surgery, all eyes were removed and prepared for light, fluoresence and transmission electron microscopy.
RESULTS: At the time of enucleation, nine eyes in the PRK group had a moderate to high degree of haze (grade 2 to 3), whereas after LASIK, all corneas showed an almost clear interface in the ablation zone. Correspondingly, all histological investigations after LASIK showed a regular stromal architecture, in contrast to the obvious anteri or stromal disorganization after PRK.
CONCLUSION: The preserved integrity of the superficial corneal layers after LASIK ensures quick wound healing with minimal tissue proliferation, resulting in a transparent corneal interface. This technique appears especially suitable for correcting high myopia.

Entities:  

Mesh:

Year:  1996        PMID: 8970022     DOI: 10.3928/1081-597X-19961101-07

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  13 in total

1.  Characterisation of corneal fibrotic wound repair at the LASIK flap margin.

Authors:  A Ivarsen; T Laurberg; T Møller-Pedersen
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

2.  Absence of IL-6 prevents corneal wound healing after deep excimer laser ablation in vivo.

Authors:  F Hafezi; Z Gatzioufas; R Angunawela; L M Ittner
Journal:  Eye (Lond)       Date:  2017-11-03       Impact factor: 3.775

3.  Corneal wound healing following laser in situ keratomileusis (LASIK): a histopathological study in rabbits.

Authors:  T Kato; K Nakayasu; Y Hosoda; Y Watanabe; A Kanai
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

4.  The role of ultraviolet-B in corneal healing following excimer laser in situ keratomileusis.

Authors:  Zoltán Zsolt Nagy; Jeannette Tóth; Attila Nagymihály; Ildikó Süveges
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

5.  Immunohistological evaluation of the healing response at the flap interface in patients with LASIK ectasia requiring penetrating keratoplasty.

Authors:  Salomon Esquenazi; Isi Esquenazi; Lev Grunstein; Juicheng He; Haydee Bazan
Journal:  J Refract Surg       Date:  2009-08       Impact factor: 3.573

6.  [Corneal wound healing after hyperopic PRK and LASIK].

Authors:  T Hammer; S Giessler; G I W Duncker; E Peschke
Journal:  Ophthalmologe       Date:  2005-01       Impact factor: 1.059

Review 7.  Refractive surgery beyond 2020.

Authors:  Marcus Ang; Damien Gatinel; Dan Z Reinstein; Erik Mertens; Jorge L Alió Del Barrio; Jorge L Alió
Journal:  Eye (Lond)       Date:  2020-07-24       Impact factor: 3.775

8.  Two-step versus Single Application of Mitomycin-C in Photorefractive Keratectomy for High Myopia.

Authors:  Farhad Fazel; Leila Roshani; Leila Rezaei
Journal:  J Ophthalmic Vis Res       Date:  2012-01

9.  A microscopy study of the structural features of post-LASIK human corneas.

Authors:  Mohammad Abahussin; Sally Hayes; Henry Edelhauser; Daniel G Dawson; Keith M Meek
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

10.  Hyeropic shift after LASIK induced diffuse lamellar keratitis.

Authors:  Tanuj Dada; Mayank S Pangtey; Namrata Sharma; Rasik B Vajpayee; Vishal Jhanji; Harinder Singh Sethi
Journal:  BMC Ophthalmol       Date:  2006-04-28       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.